메뉴 건너뛰기




Volumn 29, Issue 50, 2011, Pages 9352-9360

Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice

Author keywords

Adjuvant; CpG ODN; MAP construct; Mucosal immunity; V antigen; Yersinia

Indexed keywords

CHIMERIC PROTEIN; CPG OLIGODEOXYNUCLEOTIDE; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; LYSINE; MICROSPHERE; MULTIPLE ANTIGEN PEPTIDE; MURABUTIDE; PALMITIC ACID; POLYGLACTIN; PROTEIN LCRV; UNCLASSIFIED DRUG;

EID: 80855143740     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.129     Document Type: Article
Times cited : (20)

References (64)
  • 1
    • 0028844482 scopus 로고
    • A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model
    • Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., Titball R.W. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 1995, 13:1551-1556.
    • (1995) Vaccine , vol.13 , pp. 1551-1556
    • Russell, P.1    Eley, S.M.2    Hibbs, S.E.3    Manchee, R.J.4    Stagg, A.J.5    Titball, R.W.6
  • 2
    • 33645046626 scopus 로고    scopus 로고
    • Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery
    • Tripathi V., Chitralekha K.T., Bakshi A.R., Tomar D., Deshmukh R.A., Baig M., et al. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery. Vaccine 2006, 24:3279-3289.
    • (2006) Vaccine , vol.24 , pp. 3279-3289
    • Tripathi, V.1    Chitralekha, K.T.2    Bakshi, A.R.3    Tomar, D.4    Deshmukh, R.A.5    Baig, M.6
  • 3
    • 48849088951 scopus 로고    scopus 로고
    • Oral vaccination against bubonic plague using a live avirulent yersinia pseudotuberculosis strain
    • Blisnick T., Ave P., Huerre M., Carniel E., Demeure C.E. Oral vaccination against bubonic plague using a live avirulent yersinia pseudotuberculosis strain. Infect Immun 2008, 76:3808-3816.
    • (2008) Infect Immun , vol.76 , pp. 3808-3816
    • Blisnick, T.1    Ave, P.2    Huerre, M.3    Carniel, E.4    Demeure, C.E.5
  • 4
    • 67349128047 scopus 로고    scopus 로고
    • A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague
    • Chichester J.A., Musiychuk K., Farrance C.E., Mett V., Lyons J., Mett V., et al. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague. Vaccine 2009, 26:3471-3474.
    • (2009) Vaccine , vol.26 , pp. 3471-3474
    • Chichester, J.A.1    Musiychuk, K.2    Farrance, C.E.3    Mett, V.4    Lyons, J.5    Mett, V.6
  • 5
    • 78649626106 scopus 로고    scopus 로고
    • Different strategies for preparation of non-tagged rV270 protein and its efficacy against Yersinia pestis challenge
    • Wang W., Qi Z.Z., Zhang Q.W., Wu B.C., Zhu Z.W., Yang Y.H., et al. Different strategies for preparation of non-tagged rV270 protein and its efficacy against Yersinia pestis challenge. Biomed Environ Sci 2010, 23:333-340.
    • (2010) Biomed Environ Sci , vol.23 , pp. 333-340
    • Wang, W.1    Qi, Z.Z.2    Zhang, Q.W.3    Wu, B.C.4    Zhu, Z.W.5    Yang, Y.H.6
  • 6
    • 1842369046 scopus 로고    scopus 로고
    • Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis
    • Anderson G.P., Worsham C., Bolt G., Andrews S., Welkos, Friedlander A., et al. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am J Trop Med Hyg 1997, 56:471-473.
    • (1997) Am J Trop Med Hyg , vol.56 , pp. 471-473
    • Anderson, G.P.1    Worsham, C.2    Bolt, G.3    Andrews, S.4    Welkos5    Friedlander, A.6
  • 8
    • 33947582603 scopus 로고    scopus 로고
    • A plant-produced plague vaccine candidate confers protection to monkeys
    • Mett V., Lyons J., Musiychuk K., Chichester J.A., Brasil T., Couch R., et al. A plant-produced plague vaccine candidate confers protection to monkeys. Vaccine 2007, 25:3014-3017.
    • (2007) Vaccine , vol.25 , pp. 3014-3017
    • Mett, V.1    Lyons, J.2    Musiychuk, K.3    Chichester, J.A.4    Brasil, T.5    Couch, R.6
  • 9
    • 52049114659 scopus 로고    scopus 로고
    • Immune defense against pneumonic plague
    • Smiley S.T. Immune defense against pneumonic plague. Immunol Rev 2008, 225:256-271.
    • (2008) Immunol Rev , vol.225 , pp. 256-271
    • Smiley, S.T.1
  • 10
    • 0030777667 scopus 로고    scopus 로고
    • Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization
    • Hill J., Leary S.E.C., Griffin K.F., Williamson E.D., Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 1997, 65:4476-4482.
    • (1997) Infect Immun , vol.65 , pp. 4476-4482
    • Hill, J.1    Leary, S.E.C.2    Griffin, K.F.3    Williamson, E.D.4    Titball, R.W.5
  • 11
    • 0036303937 scopus 로고    scopus 로고
    • Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis
    • Weeks S., Hill J., Friedlander A., Welkos S. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb Pathog 2002, 32:227-237.
    • (2002) Microb Pathog , vol.32 , pp. 227-237
    • Weeks, S.1    Hill, J.2    Friedlander, A.3    Welkos, S.4
  • 13
    • 33750295380 scopus 로고    scopus 로고
    • Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen
    • Chiuchiolo M.J., Boyer J.L., Anja K., Svetlana Senina, Hackett N.R., Crystal R.G. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. J Infect Dis 2006, 194:1249-1257.
    • (2006) J Infect Dis , vol.194 , pp. 1249-1257
    • Chiuchiolo, M.J.1    Boyer, J.L.2    Anja, K.3    Svetlana Senina4    Hackett, N.R.5    Crystal, R.G.6
  • 14
    • 33846209218 scopus 로고    scopus 로고
    • Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague
    • Yang X., Hinnebusch B.J., Trunkle T., Bosio C.M., Suo Z., Tighe M., et al. Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 2007, 178:1059-1067.
    • (2007) J Immunol , vol.178 , pp. 1059-1067
    • Yang, X.1    Hinnebusch, B.J.2    Trunkle, T.3    Bosio, C.M.4    Suo, Z.5    Tighe, M.6
  • 15
    • 52949136294 scopus 로고    scopus 로고
    • Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine
    • Airhart C.L., Rohde H.N., Hovde C.J., Bohach G.A., Deobald C.F., Lee S.S., et al. Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine. Vaccine 2008, 16:5554-5561.
    • (2008) Vaccine , vol.16 , pp. 5554-5561
    • Airhart, C.L.1    Rohde, H.N.2    Hovde, C.J.3    Bohach, G.A.4    Deobald, C.F.5    Lee, S.S.6
  • 16
    • 70649091138 scopus 로고    scopus 로고
    • Protection against anthrax and plague by a combined vaccine in mice and rabbits
    • Ren J., Dong D., Zhang J., Zhang J., Liu S., Li B., et al. Protection against anthrax and plague by a combined vaccine in mice and rabbits. Vaccine 2009, 27:7436-7441.
    • (2009) Vaccine , vol.27 , pp. 7436-7441
    • Ren, J.1    Dong, D.2    Zhang, J.3    Zhang, J.4    Liu, S.5    Li, B.6
  • 17
    • 58149392737 scopus 로고    scopus 로고
    • Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates
    • Mizel S.B., Graff A.H., Sriranganathan N., Ervin S., Lees C.J., Lively M.O., et al. Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol 2009, 16:21-28.
    • (2009) Clin Vaccine Immunol , vol.16 , pp. 21-28
    • Mizel, S.B.1    Graff, A.H.2    Sriranganathan, N.3    Ervin, S.4    Lees, C.J.5    Lively, M.O.6
  • 18
    • 73949132011 scopus 로고    scopus 로고
    • Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice
    • Little S.F., Webster W.M., Wilhelm H., Fisher D., Norris S.L., Powell B.S., et al. Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice. Vaccine 2010, 28:934-939.
    • (2010) Vaccine , vol.28 , pp. 934-939
    • Little, S.F.1    Webster, W.M.2    Wilhelm, H.3    Fisher, D.4    Norris, S.L.5    Powell, B.S.6
  • 19
    • 78650763169 scopus 로고    scopus 로고
    • Hijacking of the pleiotropic cytokine interferon-γ by the type III secretion system of Yersinia pestis
    • Gendrin C., Sarrazin S., Bonnaffé D., Jault J.-M., Lortat-Jacob H., Dessen A. Hijacking of the pleiotropic cytokine interferon-γ by the type III secretion system of Yersinia pestis. PLoS One 2010, 5(12).
    • (2010) PLoS One , vol.5 , Issue.12
    • Gendrin, C.1    Sarrazin, S.2    Bonnaffé, D.3    Jault, J.-M.4    Lortat-Jacob, H.5    Dessen, A.6
  • 20
    • 77958105070 scopus 로고    scopus 로고
    • Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta
    • Qiu Y., Liu Y., Qi Z., Wang W., Kou Z., Zhang Q., et al. Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta. Scand J Immunol 2010, 72:425-433.
    • (2010) Scand J Immunol , vol.72 , pp. 425-433
    • Qiu, Y.1    Liu, Y.2    Qi, Z.3    Wang, W.4    Kou, Z.5    Zhang, Q.6
  • 21
    • 77955558220 scopus 로고    scopus 로고
    • Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA
    • Torres-Escobar A., Juárez-Rodríguez M.D., Branger C.G., Curtiss R. Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA. Vaccine 2010, 28:5810-5816.
    • (2010) Vaccine , vol.28 , pp. 5810-5816
    • Torres-Escobar, A.1    Juárez-Rodríguez, M.D.2    Branger, C.G.3    Curtiss, R.4
  • 22
    • 78149457237 scopus 로고    scopus 로고
    • Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model
    • Xiao X., Zhu Z., Dankmeyer J.L., Wormald M.M., Fast R.L., Worsham P.L., et al. Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model. PLoS One 2010, 5(10):e13047. 10.1371/journal.pone.0013047.
    • (2010) PLoS One , vol.5 , Issue.10
    • Xiao, X.1    Zhu, Z.2    Dankmeyer, J.L.3    Wormald, M.M.4    Fast, R.L.5    Worsham, P.L.6
  • 23
    • 77955553992 scopus 로고    scopus 로고
    • Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice
    • Brewoo J.N., Powell T.D., Stinchcomb D.T., Osorio J.E. Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice. Vaccine 2010, 28:5891-5899.
    • (2010) Vaccine , vol.28 , pp. 5891-5899
    • Brewoo, J.N.1    Powell, T.D.2    Stinchcomb, D.T.3    Osorio, J.E.4
  • 24
    • 79953231573 scopus 로고    scopus 로고
    • A live attenuated strain of Yersinia pestis KIM as a vaccine against plague
    • Sun W., Six D., Kuang X., Roland K.L., Raetz C.R., Curtiss R. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine 2011, 29:2986-2998.
    • (2011) Vaccine , vol.29 , pp. 2986-2998
    • Sun, W.1    Six, D.2    Kuang, X.3    Roland, K.L.4    Raetz, C.R.5    Curtiss, R.6
  • 25
    • 79960553230 scopus 로고    scopus 로고
    • Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge
    • Wang S., Goguen J.D., Li F., Lu S. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge. Vaccine 2011, (January). 10.1016/j.vaccine.2010.12.062.
    • (2011) Vaccine , Issue.JANUARY
    • Wang, S.1    Goguen, J.D.2    Li, F.3    Lu, S.4
  • 26
    • 79251561235 scopus 로고    scopus 로고
    • IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection
    • Lin J.S., Kummer L.W., Szaba F.M., Smiley S.T. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J Immunol 2011, 186:1675-1684.
    • (2011) J Immunol , vol.186 , pp. 1675-1684
    • Lin, J.S.1    Kummer, L.W.2    Szaba, F.M.3    Smiley, S.T.4
  • 27
    • 0033959430 scopus 로고    scopus 로고
    • Identification of immunodominant epitope of F1 antigen of Yersinia pestis
    • Sabhnani L., Rao D.N. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol Med Microbiol 2000, 27:155-162.
    • (2000) FEMS Immunol Med Microbiol , vol.27 , pp. 155-162
    • Sabhnani, L.1    Rao, D.N.2
  • 28
    • 37549001712 scopus 로고    scopus 로고
    • T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis
    • Khan A.A., Babu J.P., Gupta G., Rao D.N., Identifying B. T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Vaccine 2008, 26:316-332.
    • (2008) Vaccine , vol.26 , pp. 316-332
    • Khan, A.A.1    Babu, J.P.2    Gupta, G.3    Rao, D.N.4    Identifying, B.5
  • 29
    • 77449116198 scopus 로고    scopus 로고
    • 2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis
    • 2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Scand J Immunol 2010, 71:186-198.
    • (2010) Scand J Immunol , vol.71 , pp. 186-198
    • Gupta, G.1    Khan, A.A.2    Rao, D.N.3
  • 30
    • 0033960282 scopus 로고    scopus 로고
    • IgG surfaces as an important component in mucosal protection
    • Robert-Guroff M. IgG surfaces as an important component in mucosal protection. Nat Med 2000, 6:129-130.
    • (2000) Nat Med , vol.6 , pp. 129-130
    • Robert-Guroff, M.1
  • 31
    • 0020482393 scopus 로고
    • Tapping the immunological repertoire to produce antibodies of predetermined specificity
    • Lerner R.A. Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature 1982, 299:592-596.
    • (1982) Nature , vol.299 , pp. 592-596
    • Lerner, R.A.1
  • 32
    • 0022444429 scopus 로고
    • Protection of cattle against foot-and-mouth disease by a synthetic peptide
    • DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 1986, 232:639-641.
    • (1986) Science , vol.232 , pp. 639-641
    • DiMarchi, R.1    Brooke, G.2    Gale, C.3    Cracknell, V.4    Doel, T.5    Mowat, N.6
  • 33
    • 70350596217 scopus 로고    scopus 로고
    • Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles
    • Uppada J.B., Khan A.A., Bhat A.A., Deshmukh R., Rao D.N. Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles. Med Microbiol Immunol 2009, 198:247-256.
    • (2009) Med Microbiol Immunol , vol.198 , pp. 247-256
    • Uppada, J.B.1    Khan, A.A.2    Bhat, A.A.3    Deshmukh, R.4    Rao, D.N.5
  • 34
    • 0027991518 scopus 로고
    • The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides
    • Vogel T., Kurth R., Norley S. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides. J Immunol 1994, 153:1895-1904.
    • (1994) J Immunol , vol.153 , pp. 1895-1904
    • Vogel, T.1    Kurth, R.2    Norley, S.3
  • 35
    • 0025298242 scopus 로고
    • A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes
    • Del Giudice G., Tougne C., Louis J.A., Lambert P.H., Bianchi E., Bonelli F., et al. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes. Eur J Immunol 1990, 20:1619-1622.
    • (1990) Eur J Immunol , vol.20 , pp. 1619-1622
    • Del Giudice, G.1    Tougne, C.2    Louis, J.A.3    Lambert, P.H.4    Bianchi, E.5    Bonelli, F.6
  • 36
    • 0026471201 scopus 로고
    • Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein
    • Martinon F., Gras-Masse H., Boutillon C., Chirat F., Deprez B., Guillet J.G., et al. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J Immunol 1992, 149:3416-3422.
    • (1992) J Immunol , vol.149 , pp. 3416-3422
    • Martinon, F.1    Gras-Masse, H.2    Boutillon, C.3    Chirat, F.4    Deprez, B.5    Guillet, J.G.6
  • 37
    • 0028972123 scopus 로고
    • Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides
    • Sauzet J.P., Déprez B., Martinon F., Guillet J.G., Gras-Masse H., Gomard E. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides. Vaccine 1995, 14:1339-1345.
    • (1995) Vaccine , vol.14 , pp. 1339-1345
    • Sauzet, J.P.1    Déprez, B.2    Martinon, F.3    Guillet, J.G.4    Gras-Masse, H.5    Gomard, E.6
  • 38
    • 0035853029 scopus 로고    scopus 로고
    • Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice
    • Kudryashov V., Glunz P.W., Williams L.J., Hintermann S., Danishefsky S.J., et al. Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice. Proc Natl Acad Sci U S A 2001, 98:3264-3269.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 3264-3269
    • Kudryashov, V.1    Glunz, P.W.2    Williams, L.J.3    Hintermann, S.4    Danishefsky, S.J.5
  • 39
    • 0030959609 scopus 로고    scopus 로고
    • Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
    • BenMohamed L., Gras-Masse H., Tartar A., Daubersies P., Brahimi K., et al. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur J Immunol 1997, 27:1242-1253.
    • (1997) Eur J Immunol , vol.27 , pp. 1242-1253
    • BenMohamed, L.1    Gras-Masse, H.2    Tartar, A.3    Daubersies, P.4    Brahimi, K.5
  • 40
    • 60549095850 scopus 로고    scopus 로고
    • A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge
    • Zhang X., Chentoufi A.A., Dasgupta G., Nesburn A.B., Wu M., et al. A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunol 2009, 2:129-143.
    • (2009) Mucosal Immunol , vol.2 , pp. 129-143
    • Zhang, X.1    Chentoufi, A.A.2    Dasgupta, G.3    Nesburn, A.B.4    Wu, M.5
  • 41
  • 42
    • 0022618625 scopus 로고
    • Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine
    • Telzak E., Wolff S.M., Dinarello C.A., Conlon T., el Kholy A., Bahr G.M., et al. Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine. J Infect Dis 1986, 153:628-633.
    • (1986) J Infect Dis , vol.153 , pp. 628-633
    • Telzak, E.1    Wolff, S.M.2    Dinarello, C.A.3    Conlon, T.4    el Kholy, A.5    Bahr, G.M.6
  • 43
    • 12444341944 scopus 로고    scopus 로고
    • Toll-like receptors in innate immunity
    • Kiyoshi T., Shizuo A. Toll-like receptors in innate immunity. Inter Immunol 2005, 17:1-14.
    • (2005) Inter Immunol , vol.17 , pp. 1-14
    • Kiyoshi, T.1    Shizuo, A.2
  • 44
    • 0343247711 scopus 로고    scopus 로고
    • Shive Biodegradation and biocompatibility of PLA and PLGA microspheres
    • Anderson J.M., Matthew S. Shive Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997, 28(1):5-24.
    • (1997) Adv Drug Deliv Rev , vol.28 , Issue.1 , pp. 5-24
    • Anderson, J.M.1    Matthew, S.2
  • 45
    • 20044364943 scopus 로고    scopus 로고
    • Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg
    • He X.-W., Wang F., Jiang L., Li J., Liu S.-K., Xiao Z.-Y., et al. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J Gen Virol 2005, 86:601-610.
    • (2005) J Gen Virol , vol.86 , pp. 601-610
    • He, X.-W.1    Wang, F.2    Jiang, L.3    Li, J.4    Liu, S.-K.5    Xiao, Z.-Y.6
  • 47
    • 0032374350 scopus 로고    scopus 로고
    • Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines
    • Eyles J.E., Spiers I.D., Williamson E.D., Alpar O.H. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines. Vaccine 1998, 16:2000-2009.
    • (1998) Vaccine , vol.16 , pp. 2000-2009
    • Eyles, J.E.1    Spiers, I.D.2    Williamson, E.D.3    Alpar, O.H.4
  • 48
    • 58749108436 scopus 로고    scopus 로고
    • New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model
    • Florindo H.F., Pandit S., Gonçalves L.M.D., Alpar O.H., Almeida A.J. New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model. Vaccine 2009, 27:1230-1241.
    • (2009) Vaccine , vol.27 , pp. 1230-1241
    • Florindo, H.F.1    Pandit, S.2    Gonçalves, L.M.D.3    Alpar, O.H.4    Almeida, A.J.5
  • 49
    • 57349127240 scopus 로고    scopus 로고
    • Immunization with recombinant V10 protects Cynomolgus macaques from lethal pneumonic plague
    • Cornelius C.A., Quenee L.E., Overheim K.A., Koster F., Brasel T.L., Elli D., et al. Immunization with recombinant V10 protects Cynomolgus macaques from lethal pneumonic plague. Infect Immun 2008, 76:5588-5597.
    • (2008) Infect Immun , vol.76 , pp. 5588-5597
    • Cornelius, C.A.1    Quenee, L.E.2    Overheim, K.A.3    Koster, F.4    Brasel, T.L.5    Elli, D.6
  • 50
    • 33845990308 scopus 로고    scopus 로고
    • Chimeric multiple antigenic peptides for simultaneous detection of specific antibodies to HIV-1 groups M, N, O, and HIV-2
    • Pau C.-P., Luo W., McDougal J.S. Chimeric multiple antigenic peptides for simultaneous detection of specific antibodies to HIV-1 groups M, N, O, and HIV-2. J Immunol Methods 2007, 318:59-64.
    • (2007) J Immunol Methods , vol.318 , pp. 59-64
    • Pau, C.-P.1    Luo, W.2    McDougal, J.S.3
  • 51
    • 0032519965 scopus 로고    scopus 로고
    • HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160
    • VanCott T.C., Kaminski R.W., Mascola J.R., Kalyanaraman V.S., Wassef N.M., Alving C.R., et al. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immun 1998, 160:2000-2012.
    • (1998) J Immun , vol.160 , pp. 2000-2012
    • VanCott, T.C.1    Kaminski, R.W.2    Mascola, J.R.3    Kalyanaraman, V.S.4    Wassef, N.M.5    Alving, C.R.6
  • 52
    • 1242328668 scopus 로고    scopus 로고
    • The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague structure
    • Derewenda U., Mateja A., Devedjiev Y., Routzahn K.M., Evdokimov A.G., Derewenda Z.S., et al. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague structure. Structure 2004, 12:301-306.
    • (2004) Structure , vol.12 , pp. 301-306
    • Derewenda, U.1    Mateja, A.2    Devedjiev, Y.3    Routzahn, K.M.4    Evdokimov, A.G.5    Derewenda, Z.S.6
  • 53
    • 0028128469 scopus 로고
    • Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes
    • Wrightsman R.A., Dawson B.D., Fouts D.L., Manning J.E. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes. J Immunol 1994, 153:3148-3154.
    • (1994) J Immunol , vol.153 , pp. 3148-3154
    • Wrightsman, R.A.1    Dawson, B.D.2    Fouts, D.L.3    Manning, J.E.4
  • 55
    • 0024310231 scopus 로고
    • Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes
    • Tam J.P., Lu Y.A. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. Proc Natl Acad Sci U S A 1989, 86:9084-9088.
    • (1989) Proc Natl Acad Sci U S A , vol.86 , pp. 9084-9088
    • Tam, J.P.1    Lu, Y.A.2
  • 56
    • 0025789024 scopus 로고
    • Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide
    • Pessi A., Valmori D., Migliorini P., Tougne C., Bianchi E., Lambert P.H., et al. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide. Eur J Immunol 1991, 21:2273-2276.
    • (1991) Eur J Immunol , vol.21 , pp. 2273-2276
    • Pessi, A.1    Valmori, D.2    Migliorini, P.3    Tougne, C.4    Bianchi, E.5    Lambert, P.H.6
  • 57
    • 0032053462 scopus 로고    scopus 로고
    • Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein
    • Nardin E.H., Calvo-Calle J.M., Oliveira G.A., Clavijo P., Nussenzweig R., Simon R., et al. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Vaccine 1998, 16:590-600.
    • (1998) Vaccine , vol.16 , pp. 590-600
    • Nardin, E.H.1    Calvo-Calle, J.M.2    Oliveira, G.A.3    Clavijo, P.4    Nussenzweig, R.5    Simon, R.6
  • 58
    • 0025099759 scopus 로고
    • Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria
    • Tam J.P., Clavijo P., Lu Y.A., Nussenzweig V., Nussenzweig R., Zavala F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med 1990, 171:299-306.
    • (1990) J Exp Med , vol.171 , pp. 299-306
    • Tam, J.P.1    Clavijo, P.2    Lu, Y.A.3    Nussenzweig, V.4    Nussenzweig, R.5    Zavala, F.6
  • 59
    • 0036780681 scopus 로고    scopus 로고
    • Toll-like receptors as potential therapeutic targets for multiple diseases
    • Zuany-Amorim C., Hastewell J., Walker C. Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Dis 2002, 1:797-807.
    • (2002) Nat Rev Drug Dis , vol.1 , pp. 797-807
    • Zuany-Amorim, C.1    Hastewell, J.2    Walker, C.3
  • 60
    • 28644447930 scopus 로고    scopus 로고
    • TLR agonists regulate PDGF-B production and cell proliferation through TGF-β/type I IFN crosstalk
    • Chow E.K., O'Connell R.M., Schilling S., Wang X.-F., Fu X.-Y., Cheng G. TLR agonists regulate PDGF-B production and cell proliferation through TGF-β/type I IFN crosstalk. EMBO J 2005, 24:4071-4081.
    • (2005) EMBO J , vol.24 , pp. 4071-4081
    • Chow, E.K.1    O'Connell, R.M.2    Schilling, S.3    Wang, X.-F.4    Fu, X.-Y.5    Cheng, G.6
  • 61
    • 23944489407 scopus 로고    scopus 로고
    • Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
    • Napolitani G., Rinaldi A., Bertoni F., Sallusto F., Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005, 6:769-776.
    • (2005) Nat Immunol , vol.6 , pp. 769-776
    • Napolitani, G.1    Rinaldi, A.2    Bertoni, F.3    Sallusto, F.4    Lanzavecchia, A.5
  • 62
    • 77955013012 scopus 로고    scopus 로고
    • Enhanced T cell-independent antibody responses in c-Jun N-terminal kinase 2 (JNK2)-deficient B cells following stimulation with CpG-1826 and anti-IgM
    • Cao Y., Takada E., Hata K., Sudo K., Furuhata M., Mizuguchi J. Enhanced T cell-independent antibody responses in c-Jun N-terminal kinase 2 (JNK2)-deficient B cells following stimulation with CpG-1826 and anti-IgM. Immunol Lett 2010, 132:38-44.
    • (2010) Immunol Lett , vol.132 , pp. 38-44
    • Cao, Y.1    Takada, E.2    Hata, K.3    Sudo, K.4    Furuhata, M.5    Mizuguchi, J.6
  • 63
    • 78650983953 scopus 로고    scopus 로고
    • Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9
    • Allacher P., Baumgartner C.K., Pordes A.G., Ahmad R.U., Schwarz1 H.P., Reiper B.M. Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9. Blood 2011, 117:259-267.
    • (2011) Blood , vol.117 , pp. 259-267
    • Allacher, P.1    Baumgartner, C.K.2    Pordes, A.G.3    Ahmad, R.U.4    Schwarz1, H.P.5    Reiper, B.M.6
  • 64
    • 65249110570 scopus 로고    scopus 로고
    • Cutting edge lung mucosal Th17-Mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels
    • Jaffar Z., Ferrini M.E., Herritt L.A., Roberts K. Cutting edge lung mucosal Th17-Mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J Immunol 2009, 182:4507-4511.
    • (2009) J Immunol , vol.182 , pp. 4507-4511
    • Jaffar, Z.1    Ferrini, M.E.2    Herritt, L.A.3    Roberts, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.